Literature DB >> 24999248

Simultaneous determination of three glucuronide conjugates of scutellarein in rat plasma by LC-MS/MS for pharmacokinetic study of breviscapine.

Xin Wang1, Hongjun Xia2, Youping Liu1, Feng Qiu2, Xin Di3.   

Abstract

A selective and sensitive LC-MS/MS method was developed and validated for simultaneous determination of three glucuronide conjugates of scutellarein in rat plasma. Plasma samples were pretreated by protein precipitation with acetonitrile. The analytes (scutellarin, scutellarein-6,7-di-O-β-d-glucuronide and scutellarein-6-O-β-d-glucuronide), together with internal standard (IS, baicalin) were separated on a Diamonsil C18 column (150 mm × 4.6 mm, 5 μm) with an isocratic mobile phase consisting of methanol-water-formic acid (55:45:0.2, v/v/v). Mass spectrometric detection was performed by selected reaction monitoring (SRM) mode via electrospray ionization source operating in negative ionization mode. The method was linear for all the analytes over the investigated concentration ranges with correlation coefficients greater than 0.9954. The intra- and inter-day precisions were less than 9.1% and the relative error was between -1.7% and 4.2%. The extraction recoveries of the analytes and IS from rat plasma were over 63%. The validated method has been successfully applied to a pharmacokinetic study of breviscapine in rats after intragastric administration at a dose of 20mg/kg. The pharmacokinetic results would be helpful to better understand the pharmacological actions of breviscapine.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breviscapine; LC–MS/MS; Metabolite; Pharmacokinetics; Rat; Scutellarin

Mesh:

Substances:

Year:  2014        PMID: 24999248     DOI: 10.1016/j.jchromb.2014.06.013

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder.

Authors:  Ting Zhang; Xixi Li; Juewen Xu; Jingbao Shao; Meihong Ding; Senlin Shi
Journal:  Pharmaceutics       Date:  2022-04-24       Impact factor: 6.525

2.  Breviscapine Participates in the Progression of Prostate Cancer by Inhibiting ZFP91 Expression through Upregulation of MicroRNA-129-5p.

Authors:  Jie Yang; Wanjun Jin; Xiaokang Zhang; Pengcheng Chang; Duo Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-08       Impact factor: 2.629

3.  Breviscapine ameliorates CCl4‑induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation.

Authors:  Yu Liu; Pei-Hao Wen; Xin-Xue Zhang; Yang Dai; Qiang He
Journal:  Int J Mol Med       Date:  2018-05-02       Impact factor: 4.101

4.  Aristolochic Acid I-Induced Hepatotoxicity in Tianfu Broilers Is Associated with Oxidative-Stress-Mediated Apoptosis and Mitochondrial Damage.

Authors:  Dan Xu; Lizi Yin; Juchun Lin; Hualin Fu; Xi Peng; Lijen Chang; Yilei Zheng; Xiaoling Zhao; Gang Shu
Journal:  Animals (Basel)       Date:  2021-12-02       Impact factor: 2.752

5.  Characterization of metabolite profiles from the leaves of green perilla (Perilla frutescens) by ultra high performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry and screening for their antioxidant properties.

Authors:  Yeon Hee Lee; Bokyeong Kim; Soyoung Kim; Min-Sun Kim; Hyunji Kim; Seung-Ryul Hwang; Kyun Kim; Jin Hwan Lee
Journal:  J Food Drug Anal       Date:  2016-11-05       Impact factor: 6.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.